Back to Feed
总结
英国多家媒体报道，英格兰国家医疗服务体系（NHS）将扩大一款用于治疗前列腺癌的延寿药物在英格兰的可及范围，使数千名男性患者可在NHS获得该药。报道强调该药物成本较低（约2.50英镑）但可延长生存期，政策调整被认为有望挽救更多生命并减轻患者经济负担，同时反映公共医疗系统通过扩大适应人群与规范用药来提升肿瘤治疗覆盖面的趋势。
正文
Thousands of men to receive prostate cancer drug on NHS The Telegraph Life-extending prostate cancer drug to be offered to thousands in England BBC NHS expands access to prostate cancer drug in England to save thousands of lives The Guardian Drug costing just £2.50 will extend life of prostate cancer patients The Times Life-extending prostate cancer drug to be made available to thousands more patients The Independent
发布时间：